Search

Management of Localized Retinal Detachment Without PFO

Frederic Aissani, MD

Show Description +

The patient in this case presented with a progressive visual field defect due to a nasal retinal detachment with an unseen break.

Posted: 5/20/2021

Keywords:

Retinal detachment, RD

Up Next

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

Stanislao Rizzo, MD

Pinhole Effect in Double Peel for Macular Hole

Pinhole Effect in Double Peel for Macular Hole

Hudson de Carvalho Nakamura, MD

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Frederic Aissani, MD

Macular Hole Surgery: Retinal Massager

Macular Hole Surgery: Retinal Massager

Manish Nagpal, MS, DO, FRCS(UK)

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Frederic Aissani, MD

The Big Mac: ILM Technique for Large Macular Holes

The Big Mac: ILM Technique for Large Macular Holes

Hudson Nakamura, MD

ILM Peel for Macular Hole Under Liquid PFC

ILM Peel for Macular Hole Under Liquid PFC

Hudson Nakamura, MD

My Peeling Technique for a Dense Plaque on the Posterior Capsule

My Peeling Technique for a Dense Plaque on the Posterior Capsule

Ashraf Armia, FRCSG, FACS

Experience a New Dimension: How Eyetube3D Works!

Experience a New Dimension: How Eyetube3D Works!

25-Gauge Vitrectomy for Retained Lens Fragments

25-Gauge Vitrectomy for Retained Lens Fragments

Yoreh Barak, MD, Lana Rifkin, MD, Omar Saleh, MD, Shlomit Schaal, MD, PhD

Management of Localized Retinal Detachment Without PFO

Frederic Aissani, MD

The patient in this case presented with a progressive visual field defect due to a nasal retinal detachment with an unseen break.

Posted: 5/20/2021

Keywords:

Retinal detachment, RD

Please log in to leave a comment.

More in Retina

Treating GA with Avacincaptad Pegol: 3.5-Year Data

Treating GA with Avacincaptad Pegol: 3.5-Year Data

Peter K. Kaiser, MD

Decreasing Injection Burden for Patients With DME

Decreasing Injection Burden for Patients With DME

Katherine E. Talcott, MD

An Update on MCO-010 Optogenetics Therapy for Advanced RP

An Update on MCO-010 Optogenetics Therapy for Advanced RP

Vinit B. Mahajan, MD, PhD

A Potential Noninvasive Therapy for Chronic CSC

A Potential Noninvasive Therapy for Chronic CSC

Claudio Iovino, MD